INmune Bio INMB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 2.07 | 114.85 | -0.19 | -7,433 | -6 | |
| 2025Q2 | 2.31 | 100.46 | -1.06 | -24,571 | -24 | |
| 2025Q1 | 7.81 | 101.70 | -0.43 | -9,905 | -10 | |
| 2024Q4 | 4.67 | 102.70 | -0.40 | -9,467 | -9 | |
| 2024Q3 | 5.39 | 101.60 | -0.60 | -12,286 | -12 | |
| 2024Q2 | 8.82 | 101.22 | -0.50 | -9,865 | -10 | |
| 2024Q1 | 11.75 | 99.93 | -0.61 | -11,017 | -11 | |
| 2023Q4 | 11.26 | 99.66 | -0.47 | -8,379 | -8 | |
| 2023Q3 | 6.77 | 99.59 | -0.47 | -8,528 | -9 | |
| 2023Q2 | 9.08 | 98.62 | -0.37 | -6,411 | -7 | |
| 2023Q1 | 6.46 | 98.27 | -0.36 | -6,423 | -7 | |
| 2022Q4 | 6.34 | 96.73 | -0.32 | -5,642 | -6 | |
| 2022Q3 | 6.20 | 96.35 | -0.43 | -7,443 | -8 | |
| 2022Q2 | 8.84 | 93.42 | -0.38 | -6,388 | -7 | |
| 2022Q1 | 8.42 | 93.84 | -0.39 | -6,478 | -7 | |
| 2021Q4 | 10.20 | 93.37 | -0.55 | -9,030 | -10 | |
| 2021Q3 | 19.42 | 95.38 | -0.56 | -9,021 | -9 | |
| 2021Q2 | 17.57 | 98.48 | -0.45 | -6,554 | -7 | |
| 2021Q1 | 11.88 | 99.82 | -0.32 | -4,548 | -5 | |
| 2020Q4 | 17.22 | 100.16 | -0.24 | -3,209 | -3 |